University of Ulm, Dept. of Internal Medicine I
Welcome,         Profile    Billing    Logout  
 6 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Seufferlein, Thomas
PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel

Completed
3
571
Europe, Canada, US, RoW
NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel
NovoCure Ltd.
Pancreas Adenocarcinoma
10/24
10/24
MOUNTAINEER-03, NCT05253651 / 2021-002672-40: A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Recruiting
3
400
Europe, Canada, Japan, US, RoW
tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil
Seagen Inc., Merck Sharp & Dohme LLC
Colorectal Neoplasms
08/25
04/28
CANFOUR, NCT03267316 / 2017-001111-36: A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors

Completed
1/2
167
Europe
CAN04, Cisplatin, Gemcitabine, Nab-paclitaxel, Carboplatin, Pemetrexed
Cantargia AB
Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma, Triple Negative Breast Cancer, Colorectal Cancer
03/24
03/24
MEFOX, NCT05212012: D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer

Recruiting
1/2
18
Europe
Maximum tolerated dose, MTD: D,L-methadone hydrochloride (Methasan® 10 mg/ml)
AIO-Studien-gGmbH, Deutsche Krebshilfe e.V., Bonn (Germany)
Chemo-refractory Colorectal Carcinoma
06/25
06/25
ARCHES, NCT05041283: Impact of Artificial Intelligence-based Patient Reinforcement on Quality of Colonoscopy

Recruiting
N/A
258
Europe
Chatbot, Phone call
University of Ulm
Bowel Preparation
02/22
02/22
NCT04344171: CovidDB: The Covid-19 Inpatient Database

Recruiting
N/A
5000
Europe
ClarData
COVID-19
12/22
06/23
PROJECTION, NCT04246203: Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

Recruiting
N/A
200
Europe
Liquid Biopsy
Ludwig-Maximilians - University of Munich, Hoffmann-La Roche
Pancreas Cancer
12/24
12/25
PaCaReg, NCT04099134: PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma

Recruiting
N/A
5000
Europe
University of Ulm
Pancreas Adenocarcinoma, Pancreas Cancer
10/28
10/29
NCT04686409: App-based Symptom Tracking After Corona Vaccination (CoCoV)

Not yet recruiting
N/A
500
Europe
COVID-19 vaccines
University of Ulm
Adverse Events in COVID-19 Vaccination
01/22
08/22

Download Options